Quick Answer
Tempest Therapeutics, Inc. reported Total Revenue of $295.0 thousand for fiscal year 2017.
Tempest Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2017 | $295.0K | -54.8% |
| 2016 | $653.0K | +135.7% |
| 2015 | $277.0K | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | $55.0K | -1.8% | -32.1% |
| June 30, 2018 | $81.0K | -3.6% | +20.9% |
| March 31, 2018 | $67.0K | +6.3% | +19.6% |
| September 30, 2017 | $56.0K | -71.6% | -33.3% |
| June 30, 2017 | $84.0K | -55.6% | +33.3% |
| March 31, 2017 | $63.0K | -56.8% | -68.0% |
| September 30, 2016 | $197.0K | +162.7% | +4.2% |
| June 30, 2016 | $189.0K | +530.0% | +29.5% |
- Tempest Therapeutics, Inc. showed a decrease of -54.8% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Tempest Therapeutics, Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 15, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: